Keywords: CAD$, Canadian dollars; PSH, parastomal hernia; QALY, quality-adjusted life years; WTP, willing to pay
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Conceptual framework for ex-ante evaluation at the micro/macro level of GM crops with health benefits
Keywords: CBA, cost-benefit analysis; CEA, cost-effectiveness analysis; DALY, disability-adjusted life year; FBR, folate biofortified rice; GBD, Global Burden of Disease; GM, genetically modified; QALY, Quality-Adjusted Life Years; WHO, World Health Organization; W
Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis
Keywords: CPT, Current Procedural Terminology; DRG, disease-related group; ESD, endoscopic submucosal dissection; ICER, incremental cost-effectiveness ratio; m, mucosal; PPI, proton pump inhibitor; QALY, quality-adjusted life years; RFA, radiofrequency ablation
Longterm Impact of Abdominal Decompression: A Prospective Comparative Analysis
Keywords: ACS, abdominal compartment syndrome; CLOSED, patients discharged with primary fascial closure; IAH, intraabdominal hypertension; IAP, intraabdominal pressure; OPEN, patients discharged with chronic incisional hernia; QALY, quality-adjusted life years
Decision Analysis and Markov Modeling in Urology
Keywords: urology; decision support techniques; Markov chainsANN, artificial neural networks; DA, decision analysis; EV, expected value; MM, Markov model; OP, open prostatectomy; QALY, quality-adjusted life years; QOL, quality of life; RAP, robotic assisted prostat
The Cost Effectiveness of Implantable Cardioverter-Defibrillators : Results From the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
Keywords: CONV, conventional therapy; HR, hazard ratio; ICD, implantable cardioverter-defibrillator; iCER, incremental cost effectiveness ratio; MADIT-II, Second Multicenter Automatic Defibrillator Implantation Trial; QALY, quality-adjusted life years; YOLS, years-
The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes: A Cost-Effectiveness Analysis
Keywords: ACS, acute coronary syndromes; CABG, coronary artery bypass graft; GP, glycoprotein; ICER, incremental cost-effectiveness ratio; MI, myocardial infarction; OR, odds ratio; PCI, percutaneous coronary intervention; QALY, quality-adjusted life years; RR, rel